ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO945

A Distribution-Based Approach to Age Associations Between Continuous Kidney Function and Adverse Events in the General Population

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Sood, Manish M., University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada
  • Hussain, Junayd, University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada
  • Canney, Mark, University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada
  • Elliott, Meghan J., University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada
  • Hundemer, Gregory L., University of Ottawa School of Epidemiology and Public Health, Ottawa, Ontario, Canada
  • Tangri, Navdeep, University of Manitoba Max Rady College of Medicine, Winnipeg, Manitoba, Canada
Background

Whether having a low eGFR value relative to age-based medians is associated with a higher risk of an adverse event is yet to be explored. We aim to derive continuous age-specific associations between percentiles (1st, 2.5th, 5th, 10th) of eGFR and any adverse outcome (first of death, cardiovascular events, end-stage kidney disease), and obtain corresponding eGFR values.

Methods

We included 8.7 million adults (aged 18-65) with ≥1 eGFR value during January 2008-March 2020 in Ontario. Adjusted Cox models were used to estimate the association of a lower eGFR percentile (1st, 2.5th, 5th, 10th) and an adverse event by age from 18 to 65 relative to the age based median.

Results

Overall eGFR values declined with age and the risk of an adverse event was higher with an eGFR in the 10th percentile of lower across all age groups (see Figure). In younger individuals, lower percentiles of eGFR occurred at higher eGFR cutoffs relative to older individuals and were associated with an elevated risk of an adverse event. For example, an eGFR in the lowest 5th percentile would occur < 93 ml/min at age 20, < 80 ml/min at age 40, and below 65 ml/min at age 60 with corresponding adjusted HRs for an adverse event of 1.42, 1.28 and 1.32, respectively.

Conclusion

An age distribution-based approach to identifying lower eGFR values and their associated risk of an adverse event may improve care.

Figure: Trends in index estimated glomerular filtration rate (eGFR, in mL/min/1.73m2) and associated adjusted HRs of any adverse outcome (first of death, cardiovascular events, end-stage kidney disease) by continuous age